Detalhe da pesquisa
1.
ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study.
Haematologica
; 108(6): 1590-1603, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453105
2.
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome.
Haematologica
; 108(1): 181-195, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708139
3.
Salvage haploidentical or cord-blood allogeneic stem cell transplantation after a prior alternative allograft in hematologic malignancies: A retrospective study from the SFGM-TC.
Eur J Haematol
; 110(1): 40-49, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151965
4.
Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphoma.
Eur J Haematol
; 109(6): 719-727, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36048142
5.
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center.
Am J Hematol
; 95(11): 1324-1333, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32744738
6.
Small myeloid subclones are present at diagnosis of multiple myeloma in patients who develop secondary myelodysplastic syndromes.
Haematologica
; 109(4): 1289-1292, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855058
7.
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study.
Haematologica
; 107(7): 1681-1686, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965701
8.
Antithrombotic therapy and platelet transfusions in hematologic malignancy patients presenting chemotherapy-induced thrombocytopenia: a French survey.
Transfusion
; 57(7): 1717-1723, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28439927
9.
Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression.
Blood Adv
; 8(12): 3109-3119, 2024 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513135
10.
TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study.
Front Oncol
; 12: 909615, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35837095
11.
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.
Nat Genet
; 54(11): 1675-1689, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36333502
12.
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells.
Clin Nucl Med
; 46(8): 627-634, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115706
13.
[Corrigendum to: "Drug approval: Zanubrutinib in monotherapy for chronic lymphocytic leukemia" [Bull Cancer 2023;110:739-745]]. / Corrigendum à l'article « Nouvelles AMMs européenne : utilisation du zanubrutinib en monothérapie dans le traitement de la leucémie lymphoïde chronique ¼ [Bull Cancer 2023;110:744745].
Bull Cancer
; 111(1): 125, 2024 Jan.
Artigo
em Francês
| MEDLINE | ID: mdl-38182437
14.
A second round of anti-CD19 CAR T-cell therapy in diffuse large B-cell lymphoma: when persistence pays off.
Leuk Lymphoma
; 65(6): 868-871, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38440954
15.
[New drug approval: Zanubrutinib in monotherapy for chronic lymphocytic leukemia]. / Nouvelle AMM: utilisation du zanubrutinib en monothérapie dans le traitement de la leucémie lymphoïde chronique.
Bull Cancer
; 110(7-8): 744-745, 2023.
Artigo
em Francês
| MEDLINE | ID: mdl-37085342
16.
Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma.
Hemasphere
; 6(2): e675, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35141469
17.
Immunothérapie et greffe de cellules souches hématopoïétiques allogéniques.
Bull Cancer
; 103 Suppl 1: S164-S174, 2016 Nov.
Artigo
em Francês
| MEDLINE | ID: mdl-28057181
18.
[Erratum to: "Immunotherapy and allogeneic stem cells transplantation" [Bull. Cancer 103 (2016) S164-174]]. / Erratum à l'article : « Immunothérapie et greffe de cellules souches hématopïétiques et allogéniques ¼ [Bull. Cancer 103 (2016) S164174].
Bull Cancer
; 104(5): 494, 2017 05.
Artigo
em Francês
| MEDLINE | ID: mdl-28372793